XML 134 R65.htm IDEA: XBRL DOCUMENT v3.25.4
SHAREHOLDERS' EQUITY (Narrative) (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2021
Sep. 30, 2025
Stockholders Equity Note [Line Items]            
Share-based compensation cost   $ 177,011 $ 147,117 $ 100,186    
Options granted [1]   42,897        
Share-based compensation   $ 178,825 $ 148,261 $ 102,183    
Percentage of ownership   25.00%        
Shares reserved for issuance under ESPP   1,048,635 1,156,437      
Shares reduce for issuance under ESPP     778,500      
Employee Share Purchase Plan [Member]            
Stockholders Equity Note [Line Items]            
Shares reserved for issuance under ESPP         194,625  
Ordinary shares repurchased 304,269 304,269        
Share Repurchase Program [Member]            
Stockholders Equity Note [Line Items]            
Share repurchase authorization amount           $ 870,000
Share repurchase program remaining authorized amount $ 734,972 $ 734,972        
Stock repurchased and retired during period, shares   883,913        
Amount of stock repurchased and retired 135,028          
Co-CEO            
Stockholders Equity Note [Line Items]            
Options granted   22,481 74,108 73,074    
2017 share option plan            
Stockholders Equity Note [Line Items]            
Weighted-average grant-date fair value of options granted   $ 252.64 $ 217.99 $ 86.26    
Intrinsic value of options exercised   $ 123,083 $ 265,405 $ 112,799    
Unamortized share-based compensation expense $ 170,313 $ 170,313 $ 146,335 $ 118,311    
Weighted average period for cost expected to be recognized   1 year 9 months 7 days 1 year 9 months 3 days 1 year 9 months    
2021 plan            
Stockholders Equity Note [Line Items]            
Number of ordinary shares reserved and available for grant and issuance 10,841,262 10,841,262 8,941,243      
Share reserve increased   8,839,456        
Unrecognized compensation cost related to unvested restricted share units $ 164,201 $ 164,201 $ 137,265 $ 96,112    
Weighted average period for cost expected to be recognized   1 year 9 months 7 days 1 year 9 months 7 days 1 year 9 months 18 days    
2024 Foundation plan            
Stockholders Equity Note [Line Items]            
Number of ordinary shares reserved and available for grant and issuance 14,498 14,498 15,000      
Restricted Stock Units (RSUs)            
Stockholders Equity Note [Line Items]            
Options granted [2]   871,602        
Weighted-average grant-date fair value of options granted [2]   $ 258.17        
Restricted Stock Units (RSUs) | Co-CEO            
Stockholders Equity Note [Line Items]            
Options granted   62,211 48,129 22,928    
[1] Includes 73,074 performance-based options granted to the Company's Co-CEOs in 2022, 74,108 in 2023, 22,481 in 2024 and 20,217 in 2025, as applicable.
[2] Includes 22,928 performance-based awards granted to the Company’s Co-CEOs in 2023, and 48,129 performance-based awards to the Company’s Co-CEOs and several executives in 2024.